PHARMACEUTICAL SALTS OF AN OREXIN RECEPTOR ANTAGONIST

摘要

The invention is directed to pharmaceutically acceptable salts of suvorexant, which is an antagonist of orexin receptors. The pharmaceutically acceptable salts of suvorexant are useful in the treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. The invention is further directed to pharmaceutical compositions comprising pharmaceutically acceptable salts of suvorexant.

主权项

1. Crystalline suvorexant hydrochloride.